Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

BACKGROUND/AIMS: Breast cancer metastasis suppressor 1 (BRMS1) blocks metastasis in melanoma xenografts; however, its usefulness as a biomarker in human melanomas has not been widely studied. The goal was to measure BRMS1 expression in benign nevi, primary and metastatic melanomas and evaluate its i...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Slipicevic, Ana, Holm, Ruth, Emilsen, Elisabeth, Ree Rosnes, Anne Katrine, Welch, Danny R, Mælandsmo, Gunhild M, Flørenes, Vivi Ann
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2012
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3341185/
https://ncbi.nlm.nih.gov/pubmed/22356677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-73
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires